News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
FDA 483 Makes Example of Exemplar Pharma
July 11, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Specialist aerosol CDMO Exemplar Pharma has been issued with a 483 by the US FDA for inadequate process control procedures.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
MORE ON THIS TOPIC
Regulatory
Amgen deploys patients to defend troubled Tavneos in FDA hearing request
July 24, 2026
·
4 min read
·
Annalee Armstrong
Complete response letters
Update: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbump
July 23, 2026
·
3 min read
·
Tristan Manalac
China
US ‘eroding’ lead in rare diseases a matter of national security: Report
July 22, 2026
·
4 min read
·
Tristan Manalac
Podcast
Q2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2
July 22, 2026
·
1 min read
·
Jef Akst
